tion
recombin
adenoviru
primeradn
boost
regimen
alon
lymphoprolifer
secret
enhanc
heterolog
combin
immun
compar
homolog
combin
revers
sequenc
immun
regimen
lymphoprolifer
ctl
respons
significantli
weaker
compar
primeradn
boost
regimen
conclus
taken
togeth
combin
primetripl
boost
immun
radn
effect
induc
sarscovnspecif
strong
humor
cellular
immun
respons
mice
present
result
suggest
dna
immun
follow
recombin
adenoviru
boost
could
use
potenti
sarscov
vaccin
induct
enhanc
humor
cellular
immun
respons
brought
great
suffer
peopl
regard
health
economi
effort
intern
team
identifi
new
type
coronaviru
like
coronavirus
sarscov
genom
kb
length
encod
four
major
structur
protein
spike
envelop
e
membran
glycoprotein
nucleocapsid
n
protein
sever
small
nonstructur
open
read
frame
found
gene
e
gene
n
n
protein
sarscov
amino
acid
long
share
homolog
n
protein
coronavirus
previou
studi
indic
n
protein
coronavirus
extens
phosphoryl
highli
basic
associ
viral
rna
form
helic
ribonucleoprotein
compris
viral
core
structur
biolog
function
coronaviru
n
protein
thought
particip
replic
transcript
viral
rna
interfer
cell
cycl
process
host
cell
importantli
n
protein
mani
coronavirus
highli
immunogen
abundantli
express
infect
suggest
n
gene
might
critic
prophylaxi
diagnosi
sarscov
infect
genet
immun
dna
vaccin
induc
antibodi
cytotox
lymphocyt
ctl
express
classi
classii
antigenprocess
pathway
therefor
dna
vaccin
approach
appli
gener
protect
immun
variou
pathogen
date
strength
immun
respons
induc
dna
vaccin
rel
weak
compar
convent
vaccin
varieti
strategi
develop
increas
dna
vaccin
effici
approach
use
coinject
plasmid
code
immuneenhanc
gene
granulocytemacrophag
colonystimul
factor
other
aim
facilit
dna
uptak
use
liposom
encapsul
microparticl
bacteria
howev
current
one
success
protocol
recombin
viral
vector
combin
dna
vaccin
advantag
recombin
viral
vaccin
high
efficaci
gener
humor
cellular
immun
respons
number
differ
virus
adenoviru
vaccinia
rabi
viru
canarypox
viru
simian
immunodefici
viru
murin
leukemia
viru
use
construct
recombin
viral
vaccin
among
replicationdefect
recombin
adenoviru
view
favor
choic
viral
vector
vaccin
sinc
appear
safe
induc
strong
humor
cellular
antigenspecif
immun
respons
regard
clinic
characterist
sarscov
infect
develop
effici
sarscov
genet
vaccin
capabl
induc
strong
humor
cellular
respons
urgent
essenti
prevent
reemerg
current
studi
construct
sarscov
n
gene
recombin
plasmid
adenoviru
vector
radn
vaccin
inocul
balbc
mice
primetripl
boost
regimen
attempt
determin
combin
abl
induc
strong
sarscovnspecif
humor
cellular
immun
respons
cell
plasmid
cell
vero
cell
obtain
type
cultur
collect
chines
academi
scienc
shanghai
china
maintain
rpmi
medium
gibco
grand
island
ny
usa
supplement
gml
treptomycin
unitsml
penicillin
heatinactiv
fetal
bovin
serum
fb
sijiq
hangzhou
china
human
embryon
kidney
cell
purchas
invitrogen
corpor
san
diego
calif
usa
cultur
dulbecco
modifi
eagl
medium
dmem
gibco
contain
fb
lacz
gene
recombin
adenovir
express
vector
purchas
invitrogen
corpor
dna
express
plasmid
rabbit
antisera
igg
polyclon
antibodi
antisarscovn
protein
recombin
n
protein
prepar
describ
construct
replicationdefect
recombin
adenoviru
express
structur
protein
n
sarscov
radn
describ
previous
adenoviru
insert
lacz
gene
use
neg
control
viru
amplifi
cell
titer
measur
endpoint
dilut
assay
cell
plasmid
construct
transfect
cell
deriv
balbc
mous
plasmacytoma
use
lipofectamin
reagent
invitrogen
cell
cultur
rpmi
medium
supplement
gml
streptomycin
unitsml
penicillin
heatinactiv
fb
select
medium
contain
promega
madison
wisc
usa
week
stabl
clone
screen
western
blot
analysi
western
blotposit
cell
clone
treat
gml
mitomycin
c
promega
h
wash
time
subject
ctl
assay
vero
cell
infect
radn
radlacz
multipl
infect
incub
h
c
co
lyse
subject
western
blot
analysi
detect
sarscov
n
protein
express
cell
transfect
vero
cell
infect
radn
radlacz
h
transfect
infect
cell
lyse
sdspage
load
buffer
heat
min
c
protein
sampl
separ
sdspage
protein
electroblot
polyvinyliden
difluorid
membran
hybaid
heidelberg
germani
follow
block
nonspecif
proteinbind
site
use
wv
dri
milk
trisbuff
salin
contain
vv
tween
membran
incub
dilut
rabbit
antisarscovn
protein
antisera
wash
membran
incub
goat
antirabbit
horseradish
peroxidaseconjug
antibodi
secondari
antibodi
dilut
antibodi
dilut
milk
trisbuff
salin
contain
vv
tween
signal
immunoreact
band
detect
use
sensit
substrat
diaminobenzidin
kit
wuhan
boster
china
western
blot
analysi
sixto
femal
balbc
mice
purchas
shanghai
experi
anim
center
shanghai
china
divid
group
group
contain
mice
group
contain
mice
dna
immun
mice
inject
intramuscularli
im
via
quadricep
muscl
g
plasmid
dna
dissolv
l
steril
phosphatebuff
salin
pb
g
l
recombin
adenoviru
immun
mice
inject
intraperiton
ip
plaqueform
unit
radn
radlacz
dilut
ml
steril
pb
immun
interv
detail
immun
procedur
time
collect
sampl
shown
tabl
figur
fig
ii
iii
iv
show
mice
immun
week
indic
show
blood
spleen
sampl
sera
splenocyt
prepar
week
indic
order
detect
antibodi
lymphoprolifer
ctl
respons
specif
sarscovn
protein
b
ii
iii
iv
show
mice
immun
week
indic
ii
iii
iv
v
show
blood
spleen
sampl
sera
splenocyt
prepar
week
indic
order
detect
antibodi
lymphoprolifer
ctl
respons
specif
sarscovn
protein
balbc
mice
divid
group
mice
balbc
mice
group
sacrif
cervic
disloc
blood
collect
retroorbit
plexu
use
capillari
tube
week
blood
collect
incub
h
c
centrifug
min
g
supernat
transfer
new
steril
tube
inactiv
sera
incub
min
c
store
c
blood
mice
group
collect
mice
group
week
prepar
describ
antibodi
activ
sera
determin
enzymelink
immunosorb
assay
elisa
elisa
kit
diagnosi
sarscov
infect
purchas
beij
huada
aijier
corp
beij
china
kit
plate
coat
inactiv
sarscov
kit
use
accord
manufactur
instruct
absorb
measur
wavelength
nm
nm
refer
wavelength
antibodi
titer
express
rel
valu
od
nm
spleen
remov
mice
sacrif
cervic
disloc
splenocyt
separ
individu
mice
group
mice
group
week
mice
group
week
use
prolifer
detect
wash
three
time
pb
ph
splenocyt
resuspend
final
concentr
cellsml
cultur
plate
cellswel
cultur
flatbottom
plate
rpmi
medium
supplement
heatinactiv
fb
mmolml
l
glutamin
molml
mercaptoethanol
iuml
promega
detect
suspens
restimul
recombin
n
protein
gml
h
co
c
experiment
group
splenocyt
stimul
phytohemagglutinin
pha
guangzhou
china
concentr
gml
use
posit
control
without
stimul
use
neg
control
cultur
condit
assess
triplic
h
incub
plate
stain
l
bromid
mtt
roch
germani
per
well
one
hundr
microlit
dimethyl
sulfoxid
ad
well
stop
reaction
h
incub
od
valu
measur
micropl
reader
test
wavelength
nm
refer
wavelength
nm
measur
cultur
supernat
harvest
h
cultur
store
c
assay
level
measur
cultur
supernat
use
standard
elisa
assay
commerci
avail
mous
elisa
kit
jingmei
china
use
accord
manufactur
instruct
splenocyt
harvest
prepar
maintain
describ
total
splenocyt
mous
restimul
target
cell
express
n
protein
stabli
treat
mitomycin
c
day
c
co
plate
ctl
assay
target
cell
cell
ad
cellswel
plate
contain
restimul
effector
cell
splenocyt
mous
concentr
triplic
effector
target
e
cell
ratio
adjust
respect
incub
c
co
h
lactat
dehydrogenas
ldh
activ
releas
supernat
measur
follow
manufactur
instruct
ldh
detect
kit
purchas
roch
corpor
germani
maxim
ldh
releas
determin
target
cell
cultur
medium
ad
triton
spontan
ldh
releas
determin
target
cell
cultur
medium
alon
percentag
specif
cytotox
activ
calcul
experi
ldh
releasespontan
ldh
releas
maxim
ldh
releas
spontan
ldh
releas
data
studi
present
mean
sd
statist
analys
perform
spss
version
comparison
mean
humor
cellular
immun
respons
perform
twotail
test
group
mice
anova
group
case
p
consid
statist
signific
seven
sera
pool
mice
group
use
primari
antibodi
purifi
n
protein
antigen
perform
western
blot
analysi
lane
ad
sera
experiment
group
lane
ad
sera
group
neg
control
c
five
sera
pool
mice
group
use
primari
antibodi
purifi
n
protein
antigen
perform
western
blot
analysi
lane
ad
sera
experiment
group
lane
ad
sera
group
neg
control
n
p
n
p
n
p
n
p
n
p
n
p
n
p
b
fig
lymphoprolif
respons
assay
splenocyt
singl
mous
group
stimul
vitro
gml
purifi
recombin
n
protein
well
plate
experiment
group
label
gml
pha
posit
control
label
p
p
without
stimul
neg
control
label
n
n
b
splenocyt
singl
mous
group
stimul
vitro
gml
purifi
recombin
n
protein
well
plate
experiment
group
label
gml
pha
posit
control
label
without
stimul
neg
control
label
prolifer
respons
detect
mtt
method
calcul
mean
triplic
well
data
report
mean
valu
sd
od
nm
mice
group
order
detect
whether
antisera
remov
immun
mice
group
specif
n
protein
sarscov
serum
pool
immun
mice
collect
week
primari
antibodi
purifi
recombin
n
protein
antigen
subject
western
blot
analysi
describ
five
band
group
three
group
correspond
sarscovn
protein
clearli
detect
observ
lane
control
group
fig
b
c
analyz
cellular
immun
respons
splenocyt
restimul
recombin
n
protein
pha
without
stimul
use
posit
neg
experiment
control
group
respect
lymphoprolif
assay
lymphoprolif
respons
level
group
shown
figur
group
shown
figur
b
experi
lymphoprolifer
respons
immun
combin
week
maximum
among
group
slightli
weak
lymphoprolifer
respons
induc
radnradnradn
radn
combin
significantli
higher
combin
p
among
mice
group
lymphoprolifer
respons
increas
highest
level
week
induc
combin
radnradn
addit
immun
combin
observ
lymphoprolifer
respons
sustain
higher
level
week
week
immun
combin
lymphoprolifer
respons
sustain
higher
level
week
week
much
less
p
immun
boost
regimen
describ
among
mice
group
combin
induc
maximum
lymphoprolifer
respons
week
cultur
secret
detect
use
standard
elisa
result
show
mice
group
immun
combin
induc
maximum
pgml
sarscovnspecif
secret
combin
induc
rel
less
amount
pg
ml
specif
sarscovn
protein
fig
result
fig
b
combin
group
found
combin
stimul
highest
secret
gml
week
radn
combin
week
much
less
amount
stimul
combin
p
test
variou
combin
primeradn
boost
immun
revers
sequenc
immun
radn
fig
splenocyt
mice
group
immun
revers
sequenc
combin
induct
sarscovnspecif
ctl
respons
detect
week
fig
b
result
show
immun
induc
highest
level
ctl
respons
e
cell
ratio
week
two
heterogen
combin
slightli
weak
p
howev
compar
immun
boost
regimen
revers
sequenc
immun
induc
rel
weaker
ctl
respons
p
among
combin
induct
ctl
respons
immun
induc
cell
lysi
activ
e
cell
ratio
specif
sarscovn
protein
highest
level
ctl
respons
experi
genet
immun
encourag
approach
develop
effect
vaccin
control
sever
viral
infect
prevent
control
reemerg
transmiss
sarscov
except
inactiv
vaccin
experi
sever
differ
research
report
dna
vaccin
sarscov
recommend
gene
recombin
dna
vaccin
n
gene
recombin
dna
vaccin
combin
n
gene
recombin
dna
vaccin
gene
deliv
express
differ
plasmid
viral
vector
elicit
differ
level
humor
cellular
immun
respons
dna
vaccin
shown
possess
sever
import
advantag
includ
abil
induc
ctl
antibodi
classi
classii
antigenprocess
pathway
efficaci
meet
expect
differ
method
tri
increas
effect
genet
immun
prime
dna
vaccin
augment
efficaci
vaccin
base
recombin
viral
vector
rational
behind
strategi
dna
prime
elicit
lowlevel
persist
immun
follow
strong
boost
viru
encod
recombin
antigen
dna
encod
abil
primeboost
regimen
induc
higher
respons
dna
vaccin
viru
vaccin
alon
may
relat
abil
recombin
adenoviru
interfer
matur
infect
dendrit
cell
decreas
abil
present
ag
cell
preserv
effici
ag
present
cell
far
success
dna
immun
like
consecut
immun
involv
prime
plasmid
dna
boost
recombin
viru
sever
group
concentr
primeboost
immun
first
prime
dna
boost
live
viru
vector
revers
sequenc
regimen
instanc
schneider
et
al
demonstr
heterolog
prime
immun
plasmid
dna
follow
singl
boost
recombin
modifi
vaccinia
viru
ankara
provid
complet
protect
plasmodium
berghei
sporozoit
challeng
induct
high
level
epitopespecif
ctl
mice
wherea
combin
includ
viru
follow
dna
dna
follow
dna
viru
follow
viru
induc
signific
protect
thu
dna
prime
follow
viru
boost
seem
best
regimen
primeboost
immun
howev
matsui
et
al
report
dna
primeviru
boost
immun
absolut
superior
revers
sequenc
induct
hepat
c
viru
corespecif
ctl
mice
found
primedoubl
boost
immun
dna
vaccin
prime
follow
viru
boost
pcpcac
similar
efficaci
compar
fig
ldhreleas
assay
ctl
splenocyt
mice
group
prepar
week
group
b
prepar
week
respect
splenocyt
singl
mous
immun
group
restimul
vitro
n
proteinpress
cell
day
test
cytolyt
activ
ldhreleas
assay
cytolyt
activ
defin
specif
lysi
percentag
detect
e
cell
ratio
data
specif
lysi
percentag
group
calcul
mean
mice
group
experiment
point
repres
mean
triplic
well
combin
acpcpc
furthermor
compar
homolog
vector
heterogen
vector
induc
strong
antigenspecif
immun
respons
mechan
may
prime
dna
plasmid
vector
seem
decreas
develop
immun
respons
viral
vector
studi
investig
combin
induc
enhanc
humor
cellular
immun
respons
mice
immun
primeradn
boost
radn
boost
regimen
compar
homolog
prime
boost
regimen
heterogen
regimen
also
investig
mani
boost
best
mice
immun
three
combin
radn
boost
regimen
result
experi
demonstr
dna
vaccin
primeadenoviru
vector
radn
boost
regimen
greatli
enhanc
induct
humor
cellular
immun
respons
addit
studi
radn
prime
strategi
result
rel
weak
induct
immun
respons
specif
sarscov
n
protein
especi
induct
tcell
respons
immun
mice
studi
ctl
activ
regard
abil
induc
humor
respons
immun
week
immun
week
produc
similar
level
sarscovnspecif
antibodi
respons
immun
like
repeat
immun
recombin
adenoviru
vector
may
induc
suffici
vector
immun
interfer
present
transgen
upon
subsequ
boost
fact
studi
observ
antibodi
ctl
respons
enhanc
follow
third
immun
radn
repeat
radn
boost
regimen
unfortun
abl
detect
activ
primeradn
boost
induct
humor
cellular
immun
respons
week
regard
time
boost
immun
studi
immun
follow
radn
prime
gave
higher
level
humor
cellular
immun
respons
week
third
immun
fourth
immun
enhanc
significantli
therefor
principl
prime
radn
follow
boost
higher
studi
three
time
better
regimen
sarscov
infect
among
combin
primeradn
boost
radn
boost
regimen
induc
strongest
humor
cellular
immun
respons
antibodi
lymphoprolifer
product
cell
lysi
activ
e
cell
ratio
addit
sever
restrict
regard
acquisit
sar
viru
studi
purpos
remain
ascertain
whether
respons
suffici
extent
durabl
afford
protect
sarscov
infect
